Trial of Gemcitabine With or Without MSC1936369B in Pancreatic Cancer

Clinical trial NCT01016483 · COMPLETED

Trial details

NCT number: NCT01016483
Sponsor: EMD Serono
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pancreatic Adenocarcinoma

Start date: 2009-11-30
Primary completion: 2013-12-31
Enrollment: 141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.